Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 23, 2011 - Issue 11
630
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies

&
Pages 1430-1447 | Received 10 Sep 2010, Accepted 12 Jan 2011, Published online: 04 Jul 2011

References

  • Bartholow, B.N., MacQueen, K.M., Douglas, J.M., Jr, Buchbinder, S., McKirnan, D., & Judson, F.N. (1997). Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16(2), 108–115.
  • Bekker, L-G., Jaspan, H., McIntyre, J., Wood, R., & Gray, G. (2005). Adolescents and HIV vaccine trials: What are the clinical trial site issues? Journal of the International Association ofPhysicians in AIDS Care, 4(4), 93–97
  • Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D.,  Step Study Protocol Team. (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet, 372(9653), 1881–1893.
  • Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604–612.
  • Celentano, D.D., Beyrer, C., Natpratan, C., Eiumtrakul, S., Sussman, L., Renzullo, P.O.,  Nelson, K.E. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9(9), 1079–1083.
  • Chantler, T.E., Lees, A., Moxon, E.R., Mant, D., Pollard, A.J., & Fitzpatrick, R. (2007). The role familiarity with science and medicine plays in parents’ decision making about enrolling a child in vaccine research. Qualitative Health Research, 17(3), 311–322.
  • de Bruyn, G., Skhosana, N., Robertson, G., McIntyre, J.A., & Gray, G.E. (2008). Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Research Notes, 1, 76.
  • de Souza, C.T., Lowndes, C.M., Szwarcwald, C.L., Sutmöller, F., & Bastos, F.I. (2003). Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil. AIDS Care, 15(4), 539–548.
  • Deschamps, M.M., Johnson, W.D., Jr., & Pape, J.W. (1994). Feasibility and cohort development for HIV vaccine trials in Haiti. AIDS Research and Human Retroviruses, 10(Suppl. 2), S231–S233.
  • Dhalla, S., Nelson, K.E., Singer, J., & Poole, G. (2009). HIV vaccine preparedness studies in the non-Organization for Economic Co-operation and Development (non-OECD) countries. AIDS Care, 21(3), 335–348.
  • Dhalla, S., Woods, R., Strathdee, S.A., Patrick, D.M., & Hogg, R.S. (2007). HIV vaccine preparedness studies in the Organization for Economic Co-operation and Development (OECD) countries. AIDS Care, 19(9), 1118–1127.
  • Douglas, J.M., Jr., Judson, F.N., Parks, J.P., Buchbinder, S., & McKirnan, D. (1994). Participation of homosexual/bisexual men in preventive HIV vaccine trials: Baseline attitudes and concerns and predicted behaviors during trials. AIDS Research and Human Retroviruses, 10(Suppl. 2), S257–S260.
  • Duan, N. (2005). Listening to consumers and HIV vaccine preparedness. Lancet, 365(9465), 1119–1121.
  • Fincham, D., Kagee, A., & Swartz, L. (2010). Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: Construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection. AIDS Care, 22(4), 452–461.
  • Fisher, C.B. (2010). Enhancing HIV vaccine trial consent preparedness among street drug users. Journal of Empirical Research on Human Research Ethics, 5(2), 65–80.
  • Fisher, C.B., & Wallace, S.A. (2000). Through the community looking glass: Reevaluating the ethical and policy implications of research on adolescent risk and sociopathology. Ethics & Behavior, 10(2), 99–118.
  • Golub, E.T., Purvis, L.A., Sapun, M., Safaeian, M., Beyrer, C., Vlahov, D., & Strathdee, S.A. (2005). Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS and Behavior, 9(3), 301–309.
  • Hays, R.B., & Kegeles, S.M. (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(2), 164–171.
  • Jaspan, H.B., Berwick, J.R., Myer, L., Mathews, C., Flisher, A.J., Wood, R., & Bekker, L.-G. (2006). Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. Journal of Adolescent Health, 39(5), 642–648
  • Jaspan, H.B., Soka, N.F., Mathews, C., Flisher, A.J., Mark, D., Middelkoop, K.,  Bekker, L.G. (2010). A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa. International Journal of STD & AIDS, 21(3), 172–176.
  • Jenkins, R.A., Torugsa, K., Markowitz, L.E., Mason, C.J., Jamroentana, V., Brown, A.E., & Nitayaphan, S. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76(5), 386–392.
  • Koblin, B.A., Avrett, S., Taylor, P.E., & Stevens, C.E. (1997). Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15(2), 165–171.
  • Koblin, B.A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J.M. (1998). Readiness of high-risk populations in the HIV network for prevention trials to participate in HIV vaccine efficacy trials in the United States. AIDS, 12(7), 785–793.
  • Li, Q., Luo, F., Zhou, Z., Li, S., Li, Y., Li, D.,  Shao, Y. (2010). Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men. Vaccine, 28(29), 4638–4643.
  • Lindegger, G., Quayle, M., & Ndlovu, M. (2007). Local knowledge and experiences of vaccination: Implications for HIV-preventive vaccine trials in South Africa. Health Education & Behavior, 34(1), 108–123.
  • MacQueen, K.M., Buchbinder, S., Douglas, J.M., Judson, F.N., McKirnan, D.J., & Bartholow, B. (1994). The decision to enroll in HIV vaccine efficacy trials: Concerns elicited from gay men at increased risk for HIV infection. AIDS Research and Human Retroviruses, 10(Suppl. 2), S261–S264.
  • MacQueen, K.M., Vanichseni, S., Kitayaporn, D., Lin, L.S., Buavirat, A., Naiwatanakul, T.,  Mastro, T.D. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes, 21(3), 243–251.
  • McGrath, J.W., George, K., Svilar, G., Ihler, E., Mafigiri, D., Kabugo, M., & Mugisha, E. (2001a). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27(4), 381–388.
  • McGrath, J.W., Mafigiri, D., Kamya, M., George, K., Senvewo, R., Svilar, G.,  Mugisha, E. (2001b). Developing AIDS vaccine trials educational programs in Uganda. Journal of Acquired Immune Deficiency Syndromes, 26(2), 176–181.
  • Meyers, K., Metzger, D.S., Navaline, H., Woody, G.E., & McLellan, A.T. (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84(5), 761–766.
  • Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C., & Wilson, K. (2004). Barriers to participating in an HIV vaccine trial: A systematic review. AIDS, 18(17), 2235–2242.
  • Mills, E., Nixon, S., Singh, S., Dolma, S., Nayyar, A., & Kapoor, S. (2006). Enrolling women into HIV preventive vaccine trials: An ethical imperative but a logistical challenge. PLoS Medicine, 3(3), 308–311.
  • Moodley, K., Barnes, J., van Rensburg, E.J., & Myer, L. (2002). Willingness to participate in South African HIV vaccine trials-concerns of medical professionals in the Western Cape. South African Medical Journal, 92(11), 904–906.
  • Myers, D.G. (1999). Social Psychology (6th ed.). Boston, MA: McGraw-Hill College.
  • Newman, P.A., & Logie, C. (2010). HIV vaccine acceptability: A systematic review and meta-analysis. AIDS, 24(11), 1749–1756.
  • Olin, J., Kokolamami, J., Lepira, F.B., Mwandagalirwa, K., Mupenda, B., Ndongala, M.L.,  Mokili, J. (2006). Community preparedness for HIV vaccine trials in the Democratic Republic of Congo. Culture, Health & Sexuality, 8(6), 529–544.
  • Onigbogi, O.O., Kauhanen, J., & Miettola, E.J. (2005). Assessment of the knowledge and beliefs of Finnish medical students regarding HIV infection and participation in AIDS vaccine trials. International Quarterly of Community Health Education, 24(2), 123–134.
  • Périssé, A.R., Schechter, M., Moreira, R.I., do Lago, R.F., Santoro-Lopes, G., & Harrison, L.H. (2000). Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Journal of Acquired Immune Deficiency Syndromes, 25(5), 459–463.
  • Pitisuttithum, P., Choopanya, K., & Rerk-Ngnam, S. (2010). HIV-vaccine research and development in Thailand: Evolution and challenges. Vaccine, 28(Suppl. 2), B45–B49.
  • Priddy, F.H., Cheng, A.C., Salazar, L.F., & Frew, P.M. (2006). Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the southeastern US. International Journal of STD & AIDS, 17(2), 99–102.
  • Renzullo, P.O., Celentano, D.D., Beyrer, C., Eiumtrakul, S., McNeil, J.G., Garner, R.P.,  Nelson, K.E. (1999). HIV infection and risk behaviors in Thai men after their service in the Royal Thai Army: Informing vaccine cohort development. AIDS and Behavior, 3(1), 25–32.
  • Ritvo, P., Willms, D., Meisner, R., Brown, L., Goldman, A., & Sewankambo, N. (2006). Vaccine preparedness: Lessons from Lyantonde, Uganda. African Journal of AIDS Research, 5(1), 11–16.
  • Ruzagira, E., Wandiembe, S., Bufumbo, L., Levin, J., Price, M.A., Grosskurth, H., & Kamali, A. (2009). Willingness to participate in preventive HIV vaccine trials in a community based cohort in south western Uganda. Tropical Medicine & International Health, 14(2), 196–203.
  • Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K.,  Paranjape, R. (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23(11), 1351–1358.
  • Sheon, A.R. (1994). Overview: HIV vaccine feasibility studies. AIDS Research and Human Retroviruses, 10(Suppl. 2), S195–S196.
  • Sherr, L., Bolding, G., & Elford, J. (2004). Recruiting London gay men into an HIV vaccine trial: Is it feasible? AIDS Care, 16(5), 565–571.
  • Smit, J., Middelkoop, K., Myer, L., Lindegger, G., Swartz, L., Seedat, S.,  Stein, D.J. (2005). Socio-behaviour challenges to phase III HIV vaccine trials in sub-Saharan Africa. African Health Sciences, 5(3), 198–206.
  • Smit, J., Middelkoop, K., Myer, L., Seedat, S., Bekker, L-G., & Stein, D.J. (2006). Willingness to participate in HIV vaccine research in a peri-urban South African community. International Journal of STD & AIDS, 17(3), 176–179
  • Starace, F., Embrione, F., Fusco, M.L., & Cafaro, L. (2003). The psychosocial approach to the planning and implementation of vaccine trials for HIV infection. Annali dell'Instituto Superiore di Sanità, 39(2), 259–266.
  • Starace, F., Wagner, T.M., Luzi, A.M., Cafaro, L., Gallo, P., & Rezza, G. (2006). Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care, 18(1), 66–72.
  • Strauss, R.P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S.,  MacQueen, K.M. (2001). Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(1), 63–71.
  • Suhadev, M., Nyamathi, A.M., Swaminathan, S., Suresh, A., & Venkatesan, P. (2009). Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in south India. AIDS Research and Human Retroviruses, 25(2), 217–224.
  • Suhadev, M., Nyamathi, A.M., Swaminathan, S., Venkatesan, P., Raja Sakthivel, M., Shenbagavalli, R.,  Fahey, J.L. (2006). A pilot study on willingness to participate in future preventive HIV vaccine trials. The Indian Journal of Medical Research, 124(6), 631–640.
  • Sutmöller, F., Penna, T.L., de Souza, C.T., & Lambert, J. (2002). Human immunodeficiency virus incidence and risk behavior in the ‘Projeto Rio’: Results of the first 5 years of the Rio de Janeiro open cohort of homosexual and bisexual men, 1994–98. International Journal of Infectious Diseases, 6(4), 259–265.
  • Swartz, L., Kagee, A., Lesch, A., Kafaar, Z., Fincham, D.S., & Ntlemeza, B. (2006). Community members’ perceptions of facilitators and inhibitors to participation in HIV/AIDS vaccine trials. Stellenbosch: Sociobehavioural Group, South African AIDS Vaccine Initiative.
  • Tello, J., Soong, S.J., Hunter, B., Meriwethe, R., Hook, E.W., 3rd, & Mulligan, M.J. (1998). HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic. American Journal of Medical Sciences, 315(1), 11–16.
  • Valente, T.W., Zogg, J.B., Christensen, S., Richardson, J., Kovacs, A., & Operskalski, E. (2009). Using social networks to recruit an HIV vaccine preparedness cohort. Journal of Acquired Immune Deficiency Syndromes, 52(4), 514–523.
  • Yin, L., Zhang, Y., Qian, H.Z., Rui, B., Zhang, L., Zhu, J.,  Shao, Y. (2008). Willingness of Chinese injection drug users to participate in HIV vaccine trials. Vaccine, 26(6), 762–768.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.